LAMEA Stroke Management Market Analysis (2017-2023)

  • ID: 4456906
  • Report
  • 90 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
The Latin America, Middle East and Africa Stroke Management Market would witness market growth of 8.8% CAGR during the forecast period (2017 - 2023). Stroke is a medical emergency which occurs when the flow of the blood is restricted to the brain and as a result, brain cells start dying. Rise in incidence and prevalence of chronic diseases has been a major factor that is responsible for the growth of the stroke management market. Additionally, growing geriatric population, which is highly susceptible to strokes, growing diabetic population and usage of tobacco are other factors that are driving the growth of the market. However, the cost associated with the treatment and stringent government regulations pertaining to the approval of new and advances devices and drugs would limit the market growth.

Rising investments to upgrade healthcare systems and demand for technologically advanced devices for rapid & accurate distribution of medicines are the factors that are driving the market in the region. Research and development activities in the region would further add to the market attractiveness in the region. .

Based on Type, the market report segments the market into Diagnostics and Therapeutics. Diagnostics type includes Computed Tomography Scan (CT Scan), Echocardiography Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, and Other Diagnostics. Therapeutics includes Tissue Plasminogen Activator, Anticoagulant, Antiplatelet, and Antihypertensive. Based on Application, the market report segments the market into Ischemic Stroke and Haemorrhagic Stroke Based on Countries; the Stroke Management market segments the market into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the Stroke Management Market. Key companies profiled in the report include B. Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., Cardinal Health, Medtronic Plc., General Electric (GE), Merck Sharp & Dohme Corp., ABBOTT, GlaxoSmithKline plc, and Bristol-Myers Squibb.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. Braun Melsungen AG
  • Bristol-Myers Squibb.
  • Cardinal Health
  • General Electric (GE)
  • GlaxoSmithKline plc
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Latin America, Middle East and Africa Stroke Management Market, by Type
1.4.2 Latin America, Middle East and Africa Stroke Management Market, by Application
1.4.3 Latin America, Middle East and Africa Stroke Management Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Stroke Management Market
3.1 LAMEA Stroke Management Market by Type
3.1.1 LAMEA Diagnostics Market by Country
3.1.2 LAMEA Diagnostics Market by Type
3.1.2.1 LAMEA Computed Tomography Scan (CT Scan) Market by Country
3.1.2.2 LAMEA Echocardiography Market by Country
3.1.2.3 LAMEA Magnetic Resonance Imaging (MRI) Market by Country
3.1.2.4 LAMEA Carotid Ultrasound Market by Country
3.1.2.5 LAMEA Cerebral Angiography Market by Country
3.1.2.6 LAMEA Electrocardiography Market by Country
3.1.2.7 LAMEA Other Diagnostics Market by Country
3.1.3 LAMEA Therapeutics Market by Country
3.1.4 LAMEA Therapeutics Market by Type
3.1.4.1 LAMEA Tissue Plasminogen Activator Systems Market by Country
3.1.4.2 LAMEA Anticoagulant Market by Country
3.1.4.3 LAMEA Antiplatelet Market by Country
3.1.4.4 LAMEA Antihypertensive Market by Country

Chapter 4. LAMEA Stroke Management Market by Application
4.1 Introduction
4.1.1 LAMEA Stroke Management for Ischemic Stroke Market by Country
4.1.2 LAMEA Stroke Management for Haemorrhagic Stroke Market by Country

Chapter 5. LAMEA Stroke Management Market by Country
5.1 Introduction
5.2 Brazil Stroke Management Market
5.2.1 Brazil Stroke Management Market by Type
5.2.1.1 Brazil Diagnostics Market by Type
5.2.1.2 Brazil Therapeutics Market by Type
5.2.2 Brazil Stroke Management Market by Application
5.3 Argentina Stroke Management Market
5.3.1 Argentina Stroke Management Market by Type
5.3.1.1 Argentina Diagnostics Market by Type
5.3.1.2 Argentina Therapeutics Market by Type
5.3.2 Argentina Stroke Management Market by Application
5.4 UAE Stroke Management Market
5.4.1 UAE Stroke Management Market by Type
5.4.1.1 UAE Diagnostics Market by Type
5.4.1.2 UAE Therapeutics Market by Type
5.4.2 UAE Stroke Management Market by Application
5.5 Saudi Arabia Stroke Management Market
5.5.1 Saudi Arabia Stroke Management Market by Type
5.5.1.1 Saudi Arabia Diagnostics Market by Type
5.5.1.2 Saudi Arabia Therapeutics Market by Type
5.5.2 Saudi Arabia Stroke Management Market by Application
5.6 South Africa Stroke Management Market
5.6.1 South Africa Stroke Management Market by Type
5.6.1.1 South Africa Diagnostics Market by Type
5.6.1.2 South Africa Therapeutics Market by Type
5.6.2 South Africa Stroke Management Market by Application
5.7 Nigeria Stroke Management Market
5.7.1 Nigeria Stroke Management Market by Type
5.7.1.1 Nigeria Diagnostics Market by Type
5.7.1.2 Nigeria Therapeutics Market by Type
5.7.2 Nigeria Stroke Management Market by Application
5.8 Rest of LAMEA Stroke Management Market
5.8.1 Rest of LAMEA Stroke Management Market by Type
5.8.1.1 Rest of LAMEA Diagnostics Market by Type
5.8.1.2 Rest of LAMEA Therapeutics Market by Type
5.8.2 Rest of LAMEA Stroke Management Market by Application

Chapter 6. Company Profiles
6.1 B. Braun Melsungen AG.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Teleflex Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental Analysis
6.3.4 Research & Development Expense
6.4 Cardinal Health
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.5 Medtronic Plc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 General Electric (GE)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Merck Sharp & Dohme Corp.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 ABBOTT
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 GlaxoSmithKline plc
6.9.1 Financial Analysis
6.9.2 Segmental and Regional Analysis
6.9.3 Research & Development Expense
6.1 Bristol-Myers Squibb
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Teleflex Inc.
  • Cardinal Health
  • Medtronic Plc.
  • General Electric (GE)
  • Merck Sharp & Dohme Corp.
  • ABBOTT
  • GlaxoSmithKline plc
  • Bristol-Myers Squibb.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll